{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T11:32:42Z","timestamp":1785670362339,"version":"3.56.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008191","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:00:00Z","timestamp":1297814400000}}],"reference-count":97,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008191.pub2","type":"journal-article","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T18:44:12Z","timestamp":1296845052000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Antidepressants for agitation and psychosis in dementia"],"prefix":"10.1002","volume":"2011","author":[{"given":"Dallas P","family":"Seitz","sequence":"first","affiliation":[{"name":"Queen's University; Department of Psychiatry; 752 King Street West Kingston Ontario Canada K7L 4X3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikesh","family":"Adunuri","sequence":"additional","affiliation":[{"name":"University of Toronto; Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep S.","family":"Gill","sequence":"additional","affiliation":[{"name":"Queen's University; Department of Medicine; St. Mary's of the Lake Hospital 340 Union Street Kingston Ontario Canada K7L 5A2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gruneir","sequence":"additional","affiliation":[{"name":"Women's College Hospital; Women's College Research Institute; 790 Bay St. Toronto Ontario Canada M5G 1N8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[{"name":"University of Toronto; Sunnybrook Health Sciences Centre; 2075 Bayview Avenue Room FG-05 Toronto Ontario Canada M4N 3M5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Rochon","sequence":"additional","affiliation":[{"name":"Women's College Research Institute; 790 Bay Street Toronto Ontario Canada M5G1N8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,16]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD008191.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/jnp.9.4.591","article-title":"Pilot Study of Haloperidol, Fluoxetine, and Placebo for Agitation in Alzheimer's Disease","volume":"9","author":"Auchus","year":"1997","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0002|cit2","unstructured":"Clary C McRae T Griesing T Whalen E The safety of donepezil and sertraline for the management of behavioral symptoms in patients with Alzheimer's disease International Journal of Neuropsychopharmacology 2000 S267"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0003|cit3","first-page":"65","article-title":"Sertraline and Donepezil Demonstrate Similar Tolerability Compared to Donepezil Alone in Non-Depressed Patients with Alzheimer's Disease","volume":"9 (supplement 1","author":"Finkel","year":"2001","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Finkel SI Mintzer J Burt T McRae T Sertraline augmentation reduces behavioral symptoms in outpatients with Alzheimer's disease treated with donepezil. European Neuropsychopharmacology 2002 S374","DOI":"10.1016\/S0924-977X(02)80610-1"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/gps.998","article-title":"A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil","volume":"19","author":"Finkel","year":"2004","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0006|cit6","unstructured":"McRae Griesing T Whalen E Donepezil and Sertraline for the Management of Behavioral Symptoms in Patients with Alzheimer's Disease Neurology 2000 A416"},{"issue":"Supplement 7","key":"10.1002\/14651858.CD008191.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-4943(01)00135-2","article-title":"Sertraline versus small doses of haloperidol in the treatment of agitated behavior in patients with dementia","author":"Gaber","year":"2001","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"S23","key":"10.1002\/14651858.CD008191.pub2-BIB0008|cit8","first-page":"23","article-title":"Effekt av citalopram pa emosjonelle forstyrrelser hos pasienter med Alzheimer demens","volume":"45","author":"Elgen","year":"1991","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1192\/bjp.157.6.894","article-title":"The Clinical Efficacy of Emotional Disturbances in Dementia Disorders","volume":"157","author":"Nyth","year":"1990","journal-title":"Bristish Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1600-0447.1992.tb03211.x","article-title":"Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo controlled study","volume":"85","author":"Olafsson","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0011|cit11","unstructured":"Pollock B Rosen J Mulsant B Sweet R Marin R Jacob N Placebo-controlled comparison of citalopram versus perphenazine for acute treatment of severe behavioral disturbances associated with dementia. 14th Annual Meeting of the American Association for Geriatric Psychiatry San Francisco, CA 23rd - 26th February"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.159.3.460","article-title":"Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients","volume":"159","author":"Pollock","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD008191.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/JGP.0b013e3180cc1ff5","article-title":"A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia","volume":"15","author":"Pollock","year":"2007","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00019442-199705010-00008","article-title":"A Double-Blind Comparison of Trazodone and Haloperidol for Treatment of Agitation in Patients with Dementia","volume":"5","author":"Sultzer","year":"1997","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD008191.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1046\/j.1532-5415.2001.49256.x","article-title":"Does Behavioral Improvement with Haloperidol or Trazodone Depend on Psychosis or Mood Symptoms in Patients with Dementia?","volume":"49","author":"Sultzer","year":"2001","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1567205043332027","article-title":"Regreesion to the Mean: Implications for Clinical Trials of Psychotropic Agents in Dementia","volume":"1","author":"Cummings","year":"2004","journal-title":"Current Alzheimer Research"},{"issue":"9","key":"10.1002\/14651858.CD008191.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1212\/WNL.55.9.1271","article-title":"Treatment of agitation in AD: A randomized, placebo-controlled trial","volume":"55","author":"Teri","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Auer SR Monteiro I Torossian C Sinaiko E Boksay I Reisberg B The treatment of behavioral symptoms in dementia: haloperidol, thioridazine and fluoxetine: a double-blind, placebo-controlled, eight month study Neurobiology of Aging 1996 162","DOI":"10.1016\/S0197-4580(96)80654-3"},{"issue":"11","key":"10.1002\/14651858.CD008191.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/00005053-200111000-00012","article-title":"Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations","volume":"189","author":"Baumann","year":"2001","journal-title":"Journal of Nervous & Mental Disease"},{"issue":"4","key":"10.1002\/14651858.CD008191.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004850-199010000-00003","article-title":"Preliminary communication. A double-blind placebo-controlled trial of L-tryptophan to assess the degree of cognitive and behavioural improvement in patients with Alzheimer-type dementia and to compare differential response in clinical sub-groups","volume":"5","author":"Bentham","year":"1990","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD008191.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1099-1166(199705)12:5<519::AID-GPS534>3.0.CO;2-Q","article-title":"The Use of Selective Serotonin Reuptake Inhibitors for Depression and Psychosis Complicating Dementia","volume":"12","author":"Burke","year":"1997","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008191.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1099-1166(199705)12:5<519::AID-GPS534>3.0.CO;2-Q","article-title":"The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia.[see comment]","volume":"12","author":"Burke","year":"1997","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008191.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/NDT.S3201","article-title":"The efficacy of mirtazepine in agitated patients with Alzheimer's disease: A 12-week open label pilot study","volume":"4","author":"Cakir","year":"2008","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0447.1985.tb01270.x","article-title":"A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia","volume":"71","author":"Dehlin","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gps.802","article-title":"Sertraline treatment of elderly patients with depression and cognitive impairment","volume":"18","author":"Devanand","year":"2003","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008191.pub2-BIB0026|cit26","first-page":"161","article-title":"Fluoxetine in dementia of the Alzheimer's type: prominent adverse effects and failure to improve cognition","volume":"55","author":"Geldmacher","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/089198870001300201","article-title":"Citalopram for Verbal Agitation in Patients with Dementia","volume":"13","author":"Kim","year":"2000","journal-title":"Journal of Geriatric Psychiatry Neurology"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0006-3223(91)90167-K","article-title":"A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease","volume":"30","author":"Lawlor","year":"1991","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/gps.930090112","article-title":"A pilot placebo-controlled study of trazodone and buspirone in Alzheimer's disease","volume":"9","author":"Lawlor","year":"1994","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005053-200102000-00011","article-title":"Fluvoxamine for Psychosis in Alzheimer's Disease","volume":"189","author":"Levkovitz","year":"2001","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"10","key":"10.1002\/14651858.CD008191.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/appi.ajp.157.10.1686","article-title":"Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study","volume":"157","author":"Lyketsos","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gps.1048","article-title":"Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study","volume":"19","author":"Steinberg","year":"2004","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD008191.pub2-BIB0033|cit33","first-page":"A75","article-title":"Comparison of Carbamazepine and Trazodone in the Control of Aggression\/Agitation in Demented Institutionalized Patients; A Randomized Double Blind Parallel Study","volume":"39","author":"Mervis","year":"1991","journal-title":"Journal of the American Geriatric Society"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/gps.930020207","article-title":"Comparison of minaprine and placebo in the treatment of Alzheimer's disease and multi-infarct dementia","volume":"2","author":"Passeri","year":"1987","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"8432","key":"10.1002\/14651858.CD008191.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(85)91488-6","article-title":"Minaprine for senile dementia","volume":"1","author":"Passeri","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03324128","article-title":"Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study","volume":"5","author":"Passeri","year":"1993","journal-title":"Aging-Clinical & Experimental Research"},{"issue":"7","key":"10.1002\/14651858.CD008191.pub2-BIB0037|cit37","first-page":"282","article-title":"Paroxetine for verbal agitation","volume":"7","author":"Ramadan","year":"1999","journal-title":"Annals of Long-Term Care"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/ajp.146.1.45","article-title":"Double-Blind Trial of Imipramine in Alzheimer's Disease Patients With and Without Depression","volume":"146","author":"Reifler","year":"1989","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008191.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00019442-200311000-00015","article-title":"A pilot open-label trial of citalopram for restless activity and aberrant motor behaviors in Alzheimer disease","volume":"11","author":"Scharre","year":"2003","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"3 (Supplement 1","key":"10.1002\/14651858.CD008191.pub2-BIB0040|cit40","first-page":"A77","article-title":"Effectiveness of Citalopram Compared to Atypical Antipsychotics in Alzheimer's Disease Patients Who Discontinued Their Initially Assigned Treatment: CATIE-AD Phase II Results","volume":"17","author":"Schneider","year":"2009","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008191.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4088\/JCP.08m04828","article-title":"Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease","volume":"70","author":"Siddique","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0042|cit42","unstructured":"Timmons S O' Sullivan C Barry P O'Connor M O' Mahony D Twomy C Comparison of risperidone with trazodone in the management of behaviour disorder in demented elderly patients in a hospital setting: a pilot study [abstract] Irish Journal of Medical Science 2004 36"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0043|cit43","unstructured":"NCT00260624 Escitalopram treatment of patients with agitated dementia http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00260624 (accessed Aug 18 2010)."},{"key":"10.1002\/14651858.CD008191.pub2-BIB0044|cit44","unstructured":"NCT00898807 Citalopram for Agitation in Alzheimer's Disease (CitAD) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00898807"},{"issue":"20","key":"10.1002\/14651858.CD008191.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1001\/archinte.166.20.2182","article-title":"Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review","volume":"166","author":"Ayalon","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD008191.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S1041610200006773","article-title":"Behavioral and Psychological Symptoms of Dementia as a Risk Factor for Nursing Home Placement","volume":"12","author":"Balestreri","year":"2000","journal-title":"International Psychogeriatrics"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S1041610297004201","article-title":"A prospective study of psychotic symptoms in dementia sufferers: psychosis in dementia","volume":"9","author":"Ballard","year":"1997","journal-title":"International Psychogeriatrics"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0048|cit48","article-title":"Atypical antipsychotics for aggression and psychosis in Alzheimer\u2019s disease","author":"Ballard","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0049|cit49","first-page":"637","article-title":"Clinical dementia rating (CDR)","volume":"24","author":"Berg","year":"1988","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0050|cit50","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008191.pub2-BIB0051|cit51","first-page":"899","article-title":"Canadian Study of Health and Aging: study methods and prevalence of dementia","volume":"150","author":"Canadian Study of Health and Aging Working Group","year":"1994","journal-title":"Canadian Medical Association Journal"},{"issue":"4","key":"10.1002\/14651858.CD008191.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003152","article-title":"Snoezelen for dementia","author":"Chung","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD008191.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1532-5415.1986.tb04303.x","article-title":"Agitated behaviors in the elderly: II. Preliminary results in the cognitively deteriorated","volume":"34","author":"Cohen-Mansfield","year":"1986","journal-title":"Journal of the American Geriatrics Society"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"M77","DOI":"10.1093\/geronj\/44.3.M77","article-title":"A description of agitation in a nursing home","volume":"44","author":"Cohen-Mansfield","year":"1989","journal-title":"Journal of Gerontology (Medical Sciences)"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13607860120064961","article-title":"Use of drugs by old age psychiatrists in the treatment of psychotic and behavioral symptoms of dementia","volume":"5","author":"Condren","year":"2001","journal-title":"Aging and Mental Health"},{"issue":"12","key":"10.1002\/14651858.CD008191.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archinte.164.3.327","article-title":"Paroxetine-Induced Hyponatremia in Older Adults","volume":"164","author":"Fabian","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"9503","key":"10.1002\/14651858.CD008191.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"issue":"11","key":"10.1002\/14651858.CD008191.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","article-title":"Antipsychotic drug use and mortality in older adults with dementia","volume":"146","author":"Gill","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008191.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0167-4943(82)90031-0","article-title":"A new rating scale for dementia syndromes","volume":"1","author":"Gottfries","year":"1982","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S1041610205001481","article-title":"A survey of Australian and New Zealand old age psychiatrists preferred medications to treat behavioral and psychological symptoms of dementia (BPSD)","volume":"17","author":"Greve","year":"2005","journal-title":"International Psychogeriatrics"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/jnp.16.3.261","article-title":"The role of norepinephrine in the behavioral and psychological symptoms of dementia","volume":"16","author":"Herrmann","year":"2004","journal-title":"Journal of Neuropsychiatry and Clinical Neuroscience"},{"issue":"10","key":"10.1002\/14651858.CD008191.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/070674370705201004","article-title":"Pharmacological Management of Neuropsychiatric Symptoms of Alzheimer Disease","volume":"52","author":"Herrmann","year":"2007","journal-title":"Canadian Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000149584","article-title":"Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioral and psychological symptoms in dementia","volume":"26","author":"Hurt","year":"2008","journal-title":"Dementia & Geriatric Cognitive Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008191.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.npp.1301492","article-title":"ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia","volume":"33","author":"Jeste","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/jnp.13.1.5","article-title":"Role of serotonin in the behavioral and psychological symptoms of dementia","volume":"13","author":"Lanctot","year":"2001","journal-title":"Journal of Neuropsychiatry and Clinical Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/jnnp.50.2.183","article-title":"The neurobehavioral rating scale: assessment of the behavioural sequelae of head injury by the clinician","volume":"50","author":"Levin","year":"1987","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD008191.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1176\/appi.ajp.162.11.1996","article-title":"Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia","volume":"162","author":"Livingston","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002852","article-title":"Haloperidol for agitation in dementia","author":"Lonergan","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003945.pub3.","article-title":"Valproate preparations for agitation in dementia","author":"Lonergan","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD008191.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study","volume":"288","author":"Lyketsos","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004990","article-title":"Trazodone for agitation in dementia","author":"Martin\u00f3n-Torres","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD008191.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD008191.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0076|cit76","article-title":"Memantine for dementia","author":"McShane","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S1041610209008916","article-title":"Prevalence and correlates of psychotropic drug use in Dutch nursing home patients with dementia.","volume":"21","author":"Nijk","year":"2009","journal-title":"International Psychogeriatrics"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archneur.1994.00540130067012","article-title":"Severe Impairment Battery: A neuropsychological test for severely demented patients","volume":"51","author":"Panisset","year":"1994","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S1041610204000079","article-title":"Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards","volume":"16","author":"Pitkala","year":"2004","journal-title":"International Psychogeriatrics"},{"issue":"1-2","key":"10.1002\/14651858.CD008191.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000109998","article-title":"Prevalence of dementia in the United States: the aging, demographics, and memory study","volume":"29","author":"Plassman","year":"2007","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","article-title":"Effect of selective serotonin reuptake inhibitors on the risk of fracture","volume":"167","author":"Richards","year":"2007","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008191.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia diagnostic criteria for research studies","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD008191.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008191.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11319120-000000000-00000","article-title":"Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs","volume":"33","author":"Sacchetti","year":"2010","journal-title":"Drug Safety"},{"issue":"6","key":"10.1002\/14651858.CD008191.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4088\/JCP.v69n0602","article-title":"Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy","volume":"69","author":"Salzman","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008191.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.bp.108.049619","article-title":"Prevalence, correlates, and course of behavioral and psychological symptoms of dementia in the population","volume":"194","author":"Savva","year":"2009","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008191.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00019442-200111000-00004","article-title":"National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology","volume":"9","author":"Schneider","year":"2001","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"15","key":"10.1002\/14651858.CD008191.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotics drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"issue":"15","key":"10.1002\/14651858.CD008191.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008191.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/(SICI)1099-1166(199609)11:9<819::AID-GPS389>3.0.CO;2-S","article-title":"The Behavior Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): Reliability and Analysis of Symptom Category Scores","volume":"11","author":"Sclan","year":"1996","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008191.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/gps.1749","article-title":"The prevalence of psychiatric symptoms and behavioral disturbances and the use of psychotropic drugs in Norwegian nursing homes","volume":"22","author":"Selbaek","year":"2007","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008191.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence","volume":"293","author":"Sink","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD008191.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/gps.1025","article-title":"The persistance of neuropsychiatric symptoms in dementia: the Cache County Study","volume":"19","author":"Steinberg","year":"2004","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008191.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1176\/ajp.152.9.1349","article-title":"The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease","volume":"152","author":"Tariot","year":"1995","journal-title":"American Journal of Psychiatry"},{"issue":"7314","key":"10.1002\/14651858.CD008191.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.323.7314.655","article-title":"Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study","volume":"323","author":"Walraven","year":"2001","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD008191.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003477.pub2.","article-title":"Music therapy for people with dementia","author":"Vink","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD008191.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/gps.1722","article-title":"Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia","volume":"22","author":"Zuidema","year":"2007","journal-title":"International Journal of Geriatric Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008191.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:46:44Z","timestamp":1751435204000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008191.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,16]]},"references-count":97,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008191.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,16]]}}}